Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.

Thrift AP, Liu Y, Tsavachidis S, White DL, El-Serag HB.

Clin Gastroenterol Hepatol. 2018 Oct 18. pii: S1542-3565(18)31145-5. doi: 10.1016/j.cgh.2018.10.024. [Epub ahead of print]

PMID:
30342914
2.

Lung tissue microbial profile in lung cancer is distinct from emphysema.

Liu Y, O'Brien JL, Ajami NJ, Scheurer ME, Amirian ES, Armstrong G, Tsavachidis S, Thrift AP, Jiao L, Wong MC, Smith DP, Spitz MR, Bondy ML, Petrosino JF, Kheradmand F.

Am J Cancer Res. 2018 Sep 1;8(9):1775-1787. eCollection 2018.

3.

Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.

Jacobs DI, Fukumura K, Bainbridge MN, Armstrong GN, Tsavachidis S, Gu X, Doddapaneni HV, Hu J, Jayaseelan JC, Muzny DM, Huse JT, Bondy ML.

Neuro Oncol. 2018 Nov 12;20(12):1625-1633. doi: 10.1093/neuonc/noy119.

PMID:
30165405
4.

Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.

Liu Y, Lusk CM, Cho MH, Silverman EK, Qiao D, Zhang R, Scheurer ME, Kheradmand F, Wheeler DA, Tsavachidis S, Armstrong G, Zhu D, Wistuba II, Chow CB, Behrens C, Pikielny CW, Neslund-Dudas C, Pinney SM, Anderson M, Kupert E, Bailey-Wilson J, Gaba C, Mandal D, You M, de Andrade M, Yang P, Field JK, Liloglou T, Davies M, Lissowska J, Swiatkowska B, Zaridze D, Mukeriya A, Janout V, Holcatova I, Mates D, Milosavljevic S, Scelo G, Brennan P, McKay J, Liu G, Hung RJ, Christiani DC, Schwartz AG, Amos CI, Spitz MR.

J Thorac Oncol. 2018 Oct;13(10):1483-1495. doi: 10.1016/j.jtho.2018.06.016. Epub 2018 Jul 4.

PMID:
29981437
5.

Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia.

Schraw JM, Yiu TT, Lupo PJ, Tsavachidis S, Rau R, Bondy ML, Rabin KR, Shen L, Scheurer ME.

PLoS One. 2018 May 15;13(5):e0197408. doi: 10.1371/journal.pone.0197408. eCollection 2018.

6.

Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.

Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Heimberger AB, Bondy ML.

J Neurooncol. 2018 Jan;136(1):33-39. doi: 10.1007/s11060-017-2622-6. Epub 2017 Sep 30.

PMID:
28965162
7.

Combined Proteomic-Molecular Epidemiology Approach to Identify Precision Targets in Brain Cancer.

Mostovenko E, Liu Y, Amirian ES, Tsavachidis S, Armstrong GN, Bondy ML, Nilsson CL.

ACS Chem Neurosci. 2018 Jan 17;9(1):80-84. doi: 10.1021/acschemneuro.7b00165. Epub 2017 Jul 11.

8.

Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.

Liu Y, Kheradmand F, Davis CF, Scheurer ME, Wheeler D, Tsavachidis S, Armstrong G, Simpson C, Mandal D, Kupert E, Anderson M, You M, Xiong D, Pikielny C, Schwartz AG, Bailey-Wilson J, Gaba C, De Andrade M, Yang P, Pinney SM; Genetic Epidemiology of Lung Cancer Consortium, Amos CI, Spitz MR.

J Thorac Oncol. 2016 Jan;11(1):52-61. doi: 10.1016/j.jtho.2015.09.015.

9.

Genetic Modulation of Neurocognitive Function in Glioma Patients.

Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS.

Clin Cancer Res. 2015 Jul 15;21(14):3340-6. doi: 10.1158/1078-0432.CCR-15-0168. Epub 2015 Apr 22.

10.

Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.

Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S, Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Muzny DM, Gibbs RA, Melin BS, Bondy ML.

Sci Rep. 2015 Feb 5;5:8278. doi: 10.1038/srep08278.

11.

Germline mutations in shelterin complex genes are associated with familial glioma.

Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon SE, Lau CC, Parsons DW, Claus EB, Barnholtz-Sloan J, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Walsh KM, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Thompson PA, Muzny DM, Gibbs RA, Melin BS, Bondy ML; Gliogene Consortium.

J Natl Cancer Inst. 2014 Dec 7;107(1):384. doi: 10.1093/jnci/dju384. Print 2015 Jan.

12.

Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

White DL, Liu Y, Garcia J, El-Serag HB, Jiao L, Tsavachidis S, Franco LM, Lee JS, Tavakoli-Tabasi S, Moore D, Goldman R, Kuzniarek J, Ramsey DJ, Kanwal F, Marcelli M.

Int J Mol Epidemiol Genet. 2014 Oct 22;5(3):164-76. eCollection 2014.

13.

Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer.

Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS.

Cancer Res. 2014 Jun 1;74(11):2928-35. doi: 10.1158/0008-5472.CAN-13-2112.

14.

WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.

Liu Y, El-Serag HB, Jiao L, Lee J, Moore D, Franco LM, Tavakoli-Tabasi S, Tsavachidis S, Kuzniarek J, Ramsey DJ, White DL.

PLoS One. 2013 Dec 30;8(12):e84407. doi: 10.1371/journal.pone.0084407. eCollection 2013.

15.

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.

Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML.

Breast Cancer Res Treat. 2014 Jan;143(1):189-201. doi: 10.1007/s10549-013-2796-3. Epub 2013 Dec 4.

16.

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.

Gonzalez-Angulo AM, Chen H, Karuturi MS, Chavez-MacGregor M, Tsavachidis S, Meric-Bernstam F, Do KA, Hortobagyi GN, Thompson PA, Mills GB, Bondy ML, Blumenschein GR Jr.

Cancer. 2013 Jan 1;119(1):7-15. doi: 10.1002/cncr.27608. Epub 2012 Jun 26.

17.

Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.

Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Thompson PA, Chanock S; Gliogene Consortium, Bondy ML.

Hum Genet. 2012 Sep;131(9):1507-17. Epub 2012 Jun 12.

18.

Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.

Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML.

PLoS One. 2011;6(8):e23543. doi: 10.1371/journal.pone.0023543. Epub 2011 Aug 12.

19.

Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.

Brewster AM, Thompson P, Sahin AA, Do K, Edgerton M, Murray JL, Tsavachidis S, Zhou R, Liu Y, Zhang L, Mills G, Bondy M.

Cancer Prev Res (Phila). 2011 Oct;4(10):1609-16. doi: 10.1158/1940-6207.CAPR-10-0361. Epub 2011 Jul 27.

20.

Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

Mazouni C, Baggerly K, Hawke D, Tsavachidis S, André F, Buzdar AU, Martin PM, Kobayashi R, Pusztai L.

Proteomics. 2010 Oct;10(19):3525-32. doi: 10.1002/pmic.201000057.

PMID:
20827732
21.

Inherited variation in immune genes and pathways and glioblastoma risk.

Schwartzbaum JA, Xiao Y, Liu Y, Tsavachidis S, Berger MS, Bondy ML, Chang JS, Chang SM, Decker PA, Ding B, Hepworth SJ, Houlston RS, Hosking FJ, Jenkins RB, Kosel ML, McCoy LS, McKinney PA, Muir K, Patoka JS, Prados M, Rice T, Robertson LB, Schoemaker MJ, Shete S, Swerdlow AJ, Wiemels JL, Wiencke JK, Yang P, Wrensch MR.

Carcinogenesis. 2010 Oct;31(10):1770-7. doi: 10.1093/carcin/bgq152. Epub 2010 Jul 28.

22.

Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.

Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML.

Carcinogenesis. 2010 Oct;31(10):1762-9. doi: 10.1093/carcin/bgq141. Epub 2010 Jul 7.

23.

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.

Andersson U, Schwartzbaum J, Wiklund F, Sjöström S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, Johansen C, Kiuru A, Lönn S, Schoemaker MJ, Swerdlow AJ, Henriksson R, Bondy M, Melin B.

Acta Oncol. 2010 Aug;49(6):767-75. doi: 10.3109/0284186X.2010.480980.

PMID:
20446891
24.

Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.

Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, Armstrong T, Houlston R, Hosking F, Robertson L, Xiao Y, Wiencke J, Wrensch M, Andersson U, Melin BS, Bondy M.

J Clin Oncol. 2010 May 10;28(14):2467-74. doi: 10.1200/JCO.2009.26.6213. Epub 2010 Apr 5.

25.

The rapamycin-regulated gene expression signature determines prognosis for breast cancer.

Akcakanat A, Zhang L, Tsavachidis S, Meric-Bernstam F.

Mol Cancer. 2009 Sep 24;8:75. doi: 10.1186/1476-4598-8-75.

26.

Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.

Cheung HC, Hai T, Zhu W, Baggerly KA, Tsavachidis S, Krahe R, Cote GJ.

Brain. 2009 Aug;132(Pt 8):2277-88. doi: 10.1093/brain/awp153. Epub 2009 Jun 8.

27.

Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, Tang DG.

J Biol Chem. 2008 Oct 10;283(41):27957-72. doi: 10.1074/jbc.M803467200. Epub 2008 Jul 28.

28.

Molecular signatures of metastasis in head and neck cancer.

Colella S, Richards KL, Bachinski LL, Baggerly KA, Tsavachidis S, Lang JC, Schuller DE, Krahe R.

Head Neck. 2008 Oct;30(10):1273-83. doi: 10.1002/hed.20871.

29.

Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.

Cheung HC, Baggerly KA, Tsavachidis S, Bachinski LL, Neubauer VL, Nixon TJ, Aldape KD, Cote GJ, Krahe R.

BMC Genomics. 2008 May 12;9:216. doi: 10.1186/1471-2164-9-216.

30.

Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma.

Cho-Vega JH, Tsavachidis S, Do KA, Nakagawa J, Medeiros LJ, McDonnell TJ.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2615-22.

31.

Merging microarray data, robust feature selection, and predicting prognosis in prostate cancer.

Wang J, Do KA, Wen S, Tsavachidis S, McDonnell TJ, Logothetis CJ, Coombes KR.

Cancer Inform. 2007 Feb 14;2:87-97.

33.

Combined laser capture microdissection and serial analysis of gene expression from human tissue samples.

Cho-Vega JH, Troncoso P, Do KA, Rago C, Wang X, Tsavachidis S, Medeiros LJ, Spurgers K, Logothetis C, McDonnell TJ.

Mod Pathol. 2005 Apr;18(4):577-84.

Supplemental Content

Loading ...
Support Center